Found 6 matching trials
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
N/AOncotype DX® is likely to become more widely used in Europe as well as in S...
Location
Kantonsspital Baden
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
N/AThis study is a multi-center BCCA study that evaluates the impact of the On...
Location
BC Cancer Agency - Vancouver Centre
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study
N/AThe study aims to evaluate the distribution of the Oncotype DX RS® genomic ...
Location
IRCCS Ospedale San Raffaele
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
PHASE2Multiple neoadjuvant endocrine trials demonstrate that women with good prog...
Location
Washington University School of Medicine
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
PHASE2This study aims to utilize a novel biomarker-driven approach to guide neoad...
Location
Washington University School of Medicine
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer
NAA prospective population-based cohort study is being conducted in Ontario t...
Location
Simcoe Muskoka Cancer Program - Royal Victoria Hospital